tropisetron / Generic mfg.  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tropisetron / Generic mfg.
NCT01843868 / ACTRN12611001269921: Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Unknown status
N/A
130
NA
Standard anti-emetics in conjunction with R-CHOP, R-CHOP:, rituximab, doxorubicin, vincristine, cyclophosphamide, prednisolone, Anti-emetics:, ondansetron, granisetron, tropisetron, palonosetron, metoclopramide, prochlorperazine, lorazepam, aprepitant
Australasian Leukaemia and Lymphoma Group, Merck Sharp & Dohme LLC
Lymphoma, Non-Hodgkin
12/15
12/15

Download Options